C07D 209/14
Radicals substituted by nitrogen atoms, not forming part of a nitro radical
C07D209/14 (Radicals substituted by nitrogen atoms, not forming part of a nitro radical) appears on 1,490 US grants and 1,666 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,490
- Published applications
- 1,666
- Assignees
- 844
- Inventors
- 4,743
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 11 | 0 |
| 1977 | 12 | 0 |
| 1978 | 10 | 0 |
| 1979 | 9 | 0 |
| 1980 | 13 | 0 |
| 1981 | 8 | 0 |
| 1982 | 7 | 0 |
| 1983 | 7 | 0 |
| 1984 | 15 | 0 |
| 1985 | 9 | 0 |
| 1986 | 8 | 0 |
| 1987 | 11 | 0 |
| 1988 | 12 | 0 |
| 1989 | 25 | 0 |
| 1990 | 10 | 0 |
| 1991 | 13 | 0 |
| 1992 | 14 | 0 |
| 1993 | 15 | 0 |
| 1994 | 16 | 0 |
| 1995 | 18 | 0 |
| 1996 | 29 | 0 |
| 1997 | 28 | 0 |
| 1998 | 29 | 0 |
| 1999 | 24 | 0 |
| 2000 | 19 | 0 |
| 2001 | 38 | 6 |
| 2002 | 37 | 40 |
| 2003 | 35 | 64 |
| 2004 | 24 | 70 |
| 2005 | 34 | 63 |
| 2006 | 40 | 84 |
| 2007 | 33 | 76 |
| 2008 | 37 | 56 |
| 2009 | 54 | 76 |
| 2010 | 47 | 75 |
| 2011 | 42 | 53 |
| 2012 | 47 | 55 |
| 2013 | 39 | 54 |
| 2014 | 46 | 51 |
| 2015 | 42 | 76 |
| 2016 | 51 | 59 |
| 2017 | 58 | 67 |
| 2018 | 47 | 39 |
| 2019 | 38 | 52 |
| 2020 | 42 | 44 |
| 2021 | 24 | 47 |
| 2022 | 48 | 76 |
| 2023 | 52 | 110 |
| 2024 | 71 | 103 |
| 2025 | 51 | 95 |
| 2026 | 41 | 75 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Lipoxygenase inhibitors22 Sep 2026US 12,741,926 B2SRI International
- Psilocybin analogs, salts, compositions, and methods of use15 Sep 2026US 12,735,386 B2Cybin IRL Limited
- Crystalline forms of N,N-dimethyltryptamine and methods of using the same8 Sep 2026US 12,729,182 B2Atai Therapeutics, Inc.
- Compositions of matter and pharmaceutical compositions28 Jul 2026US 12,691,098 B2Atai Therapeutics, Inc.
- Cobalt-catalyzed carbonylative alkene hydrofunctionalizations promoted by visible light8 Oct 2026US 2026/0308103 A1
- Recrystallisation of 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt)8 Oct 2026US 2026/0308121 A1Gh Research Ireland Limited
- Amino acid backbone ionizable lipid, preparation method thereof and application method therefor1 Oct 2026US 2026/0294811 A1South China University of Technology
- Pyridine-piperazine-based scaffolds as highly potent and selective neurolysin activators1 Oct 2026US 2026/0294897 A1Board of Regents of the University of Nebraska
- Non-Peptide Small Molecule FGF14:Nav1.6 Channel Complex Protein-Protein Interaction Modulators1 Oct 2026US 2026/0297027 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- Heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them565US 5,514,718 AMerck Sharp & Dohme Corp. · 1996
- Deacetylase inhibitors168US 6,552,065 B2Novartis AG · 2003
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Tumor-targeted optical contrast agents142US 7,198,778 B2Mallinckrodt Inc. · 2007
- Urea derivatives and their use as ACAT inhibitors134US 5,621,010 ANisshin Flour Milling Co., Ltd. · 1997